Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

This study has been completed.
Information provided by (Responsible Party):
Celltrion Identifier:
First received: October 4, 2010
Last updated: March 11, 2013
Last verified: March 2013